Spinnaker Trust’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$901K Hold
14,848
0.05% 156
2025
Q4
$801K Sell
14,848
-258
-2% -$12.4K 0.04% 167
2025
Q3
$681K Sell
15,106
-212
-1% -$9.9K 0.04% 180
2025
Q2
$709K Hold
15,318
0.04% 176
2025
Q1
$934K Sell
15,318
-715
-4% -$41.7K 0.06% 150
2024
Q4
$907K Buy
16,033
+1,113
+7% +$62.2K 0.06% 150
2024
Q3
$772K Sell
14,920
-310
-2% -$14.5K 0.05% 165
2024
Q2
$633K Buy
15,230
+194
+1% +$8.68K 0.04% 179
2024
Q1
$815K Sell
15,036
-3,705
-20% -$189K 0.05% 152
2023
Q4
$962K Sell
18,741
-23,191
-55% -$1.22M 0.07% 142
2023
Q3
$2.43M Buy
41,932
+1,385
+3% +$84.9K 0.18% 91
2023
Q2
$2.59M Buy
40,547
+7,906
+24% +$530K 0.19% 90
2023
Q1
$2.26M Sell
32,641
-198
-0.6% -$14K 0.17% 93
2022
Q4
$2.36M Buy
32,839
+370
+1% +$27.9K 0.18% 94
2022
Q3
$2.31M Buy
32,469
+82
+0.3% +$5.95K 0.19% 91
2022
Q2
$2.49M Buy
32,387
+4,775
+17% +$364K 0.19% 96
2022
Q1
$2.02M Buy
27,612
+250
+0.9% +$16.8K 0.14% 109
2021
Q4
$1.71M Sell
27,362
-1,671
-6% -$98K 0.11% 114
2021
Q3
$1.72M Buy
29,033
+392
+1% +$25.8K 0.12% 106
2021
Q2
$1.91M Sell
28,641
-30,559
-52% -$1.99M 0.13% 104
2021
Q1
$3.74M Buy
59,200
+6,377
+12% +$397K 0.28% 71
2020
Q4
$3.28M Sell
52,823
-1,830
-3% -$113K 0.26% 76
2020
Q3
$3.29M Buy
54,653
+1,086
+2% +$65.4K 0.29% 67
2020
Q2
$3.15M Buy
53,567
+231
+0.4% +$13.8K 0.3% 72
2020
Q1
$2.97M Sell
53,336
-4,102
-7% -$251K 0.33% 71
2019
Q4
$3.69M Buy
57,438
+1,060
+2% +$60.7K 0.34% 65
2019
Q3
$2.86M Buy
56,378
+192
+0.3% +$9.02K 0.28% 76
2019
Q2
$2.55M Buy
56,186
+3,694
+7% +$172K 0.26% 75
2019
Q1
$2.5M Buy
52,492
+964
+2% +$48K 0.25% 80
2018
Q4
$2.68M Buy
51,528
+4,362
+9% +$234K 0.3% 66
2018
Q3
$2.93M Buy
47,166
+2,167
+5% +$129K 0.29% 69
2018
Q2
$2.49M Buy
44,999
+4,365
+11% +$236K 0.27% 72
2018
Q1
$2.57M Buy
40,634
+75
+0.2% +$4.83K 0.28% 67
2017
Q4
$2.48M Sell
40,559
-510
-1% -$31.9K 0.29% 67
2017
Q3
$2.62M Sell
41,069
-13,324
-24% -$778K 0.33% 65
2017
Q2
$3.03M Buy
54,393
+598
+1% +$32.5K 0.38% 52
2017
Q1
$2.92M Sell
53,795
-174
-0.3% -$9.54K 0.38% 51
2016
Q4
$3.15M Buy
53,969
+9,880
+22% +$540K 0.42% 43
2016
Q3
$2.38M Buy
44,089
+12,667
+40% +$814K 0.32% 61
2016
Q2
$2.31M Buy
31,422
+23,732
+309% +$1.68M 0.32% 61
2016
Q1
$491K Sell
7,690
-16
-0.2% -$1.01K 0.07% 133
2015
Q4
$530K Sell
7,706
-253
-3% -$16.7K 0.08% 133
2015
Q3
$471K Buy
7,959
+200
+3% +$12.7K 0.07% 139
2015
Q2
$516K Sell
7,759
-601
-7% -$39.6K 0.08% 135
2015
Q1
$539K Sell
8,360
-680
-8% -$42.6K 0.08% 131
2014
Q4
$534K Sell
9,040
-537
-6% -$30.3K 0.08% 122
2014
Q3
$490K Hold
9,577
0.08% 130
2014
Q2
$465K Sell
9,577
-1,000
-9% -$49.3K 0.08% 125
2014
Q1
$549K Buy
10,577
+233
+2% +$12.4K 0.09% 116
2013
Q4
$550K Sell
10,344
-1,055
-9% -$53.7K 0.09% 109
2013
Q3
$528K Sell
11,399
-300
-3% -$13.2K 0.1% 110
2013
Q2
$523K Buy
+11,699
New +$508K 0.1% 106

Other funds holding BMY

Spinnaker Trust's BMY Position: Q1 2026 in Review

Spinnaker Trust held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 14,848 shares worth $901K. The position accounts for 0.05% of the portfolio, ranked #156.

Spinnaker Trust first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.74M in Q1 2021. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Spinnaker Trust held 14,848 shares of Bristol-Myers Squibb worth $901K as of Q1 2026.
  • Spinnaker Trust left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.05% of Spinnaker Trust's portfolio in Q1 2026, its #156 holding.
  • Spinnaker Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Spinnaker Trust's Bristol-Myers Squibb position peaked at $3.74M in Q1 2021.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Spinnaker Trust's 13F filing for Q1 2026, filed 23 Apr 2026.